Literature DB >> 26076881

Molecular and clinical features of inherited neuropathies due to PMP22 duplication.

M M Watila1, S A Balarabe2.   

Abstract

PMP22 is a transmembrane glycoprotein component of myelin, important for myelin functioning. Mutation of PMP22 gene which encodes for the production of PMP22 glycoprotein is associated with a variety of inherited neuropathies. This literature review sought to review the molecular mechanism and clinical features of inherited neuropathies caused by PMP22 duplication. PMP22 duplication causes CMT1A which accounts for more than half of all CMT cases and about 70% of CMT1 cases. It manifests with muscle weakness, depressed reflexes, impaired distal sensation, hand and foot deformities, slowing of NCV and onion bulbs. With no specific treatment available, it is managed conservatively. Future treatment may be based on the molecular genetics of the disease.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CMT1A; Duplication; Myelin; Nerve; Neuropathies; PMP22

Mesh:

Substances:

Year:  2015        PMID: 26076881     DOI: 10.1016/j.jns.2015.05.037

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  12 in total

1.  PMP22 Gene-Associated Neuropathies: Phenotypic Spectrum in a Cohort from India.

Authors:  Madhu Nagappa; Shivani Sharma; Periyasamy Govindaraj; Yasha T Chickabasaviah; Ramesh Siram; Akhilesh Shroti; Monojit Debnath; Sanjib Sinha; Parayil S Bindu; Arun B Taly
Journal:  J Mol Neurosci       Date:  2020-01-28       Impact factor: 3.444

2.  Validation of differential GDAP1 DNA methylation in alcohol dependence and its potential function as a biomarker for disease severity and therapy outcome.

Authors:  Christof Brückmann; Adriana Di Santo; Kathrin Nora Karle; Anil Batra; Vanessa Nieratschker
Journal:  Epigenetics       Date:  2016-04-29       Impact factor: 4.528

Review 3.  New evidence for secondary axonal degeneration in demyelinating neuropathies.

Authors:  Kathryn R Moss; Taylor S Bopp; Anna E Johnson; Ahmet Höke
Journal:  Neurosci Lett       Date:  2020-12-24       Impact factor: 3.046

4.  Clinical and Pathological Variation of Charcot-Marie-Tooth 1A in a Large Chinese Cohort.

Authors:  Rui Wu; He Lv; Wei Zhang; Zhaoxia Wang; Yuehuan Zuo; Jing Liu; Yun Yuan
Journal:  Biomed Res Int       Date:  2017-08-01       Impact factor: 3.411

5.  Unmasking a Case of Asymptomatic Charcot-Marie-Tooth Disease (CMT1A) With Vincristine.

Authors:  Roopam Jariwal; Basel Shoua; Katayoun Sabetian; Piruthiviraj Natarajan; Everardo Cobos
Journal:  J Investig Med High Impact Case Rep       Date:  2018-02-26

6.  Cell transplantation strategies for acquired and inherited disorders of peripheral myelin.

Authors:  A K M G Muhammad; Kevin Kim; Irina Epifantseva; Arwin Aghamaleky-Sarvestany; Megan E Simpkinson; Sharon Carmona; Jesse Landeros; Shaughn Bell; John Svaren; Robert H Baloh
Journal:  Ann Clin Transl Neurol       Date:  2018-01-22       Impact factor: 4.511

7.  Influence of Genetically Modified Human Umbilical Cord Blood Mononuclear Cells on the Expression of Schwann Cell Molecular Determinants in Spinal Cord Injury.

Authors:  L R Galieva; Y O Mukhamedshina; E R Akhmetzyanova; Z E Gilazieva; S S Arkhipova; E E Garanina; A A Rizvanov
Journal:  Stem Cells Int       Date:  2018-02-18       Impact factor: 5.443

8.  Melatonin Treatment Reduces Oxidative Damage and Normalizes Plasma Pro-Inflammatory Cytokines in Patients Suffering from Charcot-Marie-Tooth Neuropathy: A Pilot Study in Three Children.

Authors:  Mariam Chahbouni; María Del Señor López; Antonio Molina-Carballo; Tomás de Haro; Antonio Muñoz-Hoyos; Marisol Fernández-Ortiz; Ana Guerra-Librero; Darío Acuña-Castroviejo
Journal:  Molecules       Date:  2017-10-14       Impact factor: 4.411

9.  Squalenoyl siRNA PMP22 nanoparticles are effective in treating mouse models of Charcot-Marie-Tooth disease type 1 A.

Authors:  Suzan Boutary; Marie Caillaud; Mévidette El Madani; Jean-Michel Vallat; Julien Loisel-Duwattez; Alice Rouyer; Laurence Richard; Céline Gracia; Giorgia Urbinati; Didier Desmaële; Andoni Echaniz-Laguna; David Adams; Patrick Couvreur; Michael Schumacher; Charbel Massaad; Liliane Massaad-Massade
Journal:  Commun Biol       Date:  2021-03-09

Review 10.  New Therapeutics Options for Pediatric Neuromuscular Disorders.

Authors:  Marina Flotats-Bastardas; Andreas Hahn
Journal:  Front Pediatr       Date:  2020-11-23       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.